An RNA Interference Phenotypic Screen Identifies a Role for FGF Signals in Colon Cancer Progression

• Marc Leushacke,

  Affiliations Department of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany, Department of Biology, Chemistry and Pharmacy, Free University Berlin, Berlin, Germany

  ⨯
• Ralf Spörle,

  Affiliation Department of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany

  ⨯
• Christof Bernemann,

  Affiliation Department of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany

  ⨯
• Antje Brouwer-Lehmitz,

  Affiliation Department of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany

  ⨯
• Johannes Fritzmann,

  Affiliations Max Delbrück Center for Molecular Medicine, Berlin, Germany, Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany

  ⨯
• Mirko Theis,

  Affiliations Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany, University Hospital Carl Gustav Carus and Medical Faculty, University of Technology Dresden, Dresden, Germany

  ⨯
• Frank Buchholz,

  Affiliations Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany, University Hospital Carl Gustav Carus and Medical Faculty, University of Technology Dresden, Dresden, Germany

  ⨯
• Bernhard G. Herrmann,

  Affiliations Department of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany, Institute for Medical Genetics, Charité Campus Benjamin Franklin, Berlin, Germany

  ⨯
• Markus Morkel

  * E-mail: morkel@molgen.mpg.de

  Affiliation Department of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany

  ⨯